"Serving Buffalo and Western New York communities, Mercy Hospital of Buffalo is a tertiary care center that offers the highest level of stroke and heart care. Accredited by the Joint Commission to treat the most complex stroke cases, we also deliver a full range of cardiac care."

During the past decade, Mercy Hospital of Buffalo conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital of Buffalo" #1 sponsor was "University of Miami" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Columbia University" with 1 trials sponsored and "DiaMedica Therapeutics Inc" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital of Buffalo" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Abiomed Inc." with 1 trials as a collaborator, "American Heart Association" with 1 trials as a collaborator and "Chiesi Farmaceutici S.p.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital of Buffalo" are "Ischemic Stroke" (3 trials), "Covid19" (2 trials), "Acute Myocardial Infarction" (1 trials), "Acute Stroke" (1 trials) and "Arteriovenous Malformations, Cerebral" (1 trials). Many other conditions were trialed in "Mercy Hospital of Buffalo" in a lesser frequency.

Most popular intervention types in "Mercy Hospital of Buffalo" are "Drug" (4 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMPLATZER PFO Occluder" (1 trials), "Albumin" (1 trials), "Apixaban 2.5 MG" (1 trials), "Carotid WALLSTENT Monorail Endoprosthesis" (1 trials) and "Crizanlizumab Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital of Buffalo" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Hospital of Buffalo". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Mercy Hospital of Buffalo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital of Buffalo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".